Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.99x is 99% above its 5-year average of -253.61x, near the high end of its 5-year range (-1254.67x–0.24x).
99.74% above its 12-month average of -778.56x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1081.00x.
INTEREST COVERAGE RATIO
-1.99x
INTEREST COVERAGE RATIO AVG TTM
-778.56x
INTEREST COVERAGE RATIO AVG 3Y
-334.29x
INTEREST COVERAGE RATIO AVG 5Y
-253.61x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+99.74%
CURRENT VS 3Y AVG
+99.40%
CURRENT VS 5Y AVG
+99.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+69.10%
vs the sector median at left
Polyrizon Ltd.
Market Cap
$10.83M
Interest Coverage Ratio
-1.99x
TTM Avg
-778.56x
3Y Avg
-334.29x
5Y Avg
-253.61x
Market Cap
$10.68M
Interest Coverage Ratio
26.76x
TTM Avg
26.76x
3Y Avg
26.76x
5Y Avg
26.76x
Market Cap
$11.00M
Interest Coverage Ratio
-219.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.08M
Interest Coverage Ratio
-473.91x
TTM Avg
210.31x
3Y Avg
210.31x
5Y Avg
210.31x
Market Cap
$11.12M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polyrizon Ltd. (PLRZ) | $10.83M | -1.99x | -778.56x | -334.29x | -253.61x |
| BioVie Inc. (BIVI)vs › | $10.86M | -1265.39x | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -4.24x | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $10.68M | 26.76x | 26.76x | 26.76x | 26.76x |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | -219.72x | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.02M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | -473.91x | 210.31x | 210.31x | 210.31x |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | N/A | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $11.36M | -309.66x | N/A | N/A | N/A |
Interest Coverage
-2.0x
Debt/Equity
0.00
Current Ratio
36.37
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1081.00x |
| 2025-12-31 | -1254.67x |
| 2025-06-30 | 0.00x |
| 2025-03-31 | 0.00x |
| 2024-12-31 | 0.24x |
| 2024-06-30 | -1.44x |
| 2023-12-31 | -3.13x |
| 2022-06-30 | -28.60x |
| 2021-12-31 | -92.00x |
| 2021-06-30 | -75.50x |
| 2020-06-30 | -3.33x |
